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1. Introduction  
Malignant mesothelioma is an asbestos-associated malignancy arising from the mesothelial 
cells of the pleural and peritoneal cavities, as well as the pericardium and the tunica vaginalis. 
Mesothelioma usually presents in the fifth to seventh decades, and 70-80 % of cases occur in 
men (Moore et al., 2008). Malignant pleural mesothelioma (MPM) is the most widely form of 
mesothelioma. Patients frequently present with dyspnea, chest pain, cough, and weight loss 
(Moore et al., 2008, Wang et al., 2004). Although most of the mesotheliomas cover the 
pleural surface, approximately 35% arise only from peritoneum. Patients with malignant 
peritoneal mesothelioma may present with abdominal pain, distention, anorexia, and 
weight loss (Park et al., 2008). 
Radiologic modalities play a crucial role in the evaluation of malignant mesothelioma. 
Computed tomography is the primary imaging method used for the diagnosis and the 
staging of malignant mesothelioma, but also for guiding biopsy for tissue diagnosis. 
Magnetic resonans imaging (MRI) is useful for detection of extension of disease, especially 
to the chest wall and diaphragm (Moore et al., 2008, Wang et al., 2004). In this article we 
review radiologic findings of malignant pleural and peritoneal mesothelioma with our 
patient archives. We also wants to give some information about differential diagnosis 
malignant pleural and peritoneal mesothelioma.  
2. Material and methods 
We scanned our patient archive of mesothelioma between 2008-2011 years. We accepted 
patients who had CT or MRI at their initial diagnosis. We have had 135 patient who suffered 
from mesothelioma but only 35 patient had CT or MRI at the time of diagnosis. Twenty 
seven of them were pleural mesothelioma, and 8 of them peritoneal mesothelioma.  
3. Results  
In pleural mesothelioma group, there were 10 women (37%) and 17 men (63%). The 
avarage age was 55.14±12.47 (min: 29 - max: 87). We found pleural effusion in 23 patients 
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(85.12%), pleural thickening in 27 patients (100%) (Fig. 1.,2.), pleural calcification in 11 
patients (40.7%) ( Fig.1.), lymphadenopathy in 11 patients (40.7%) (Fig. 1., 4., 6.), direct 
extension to mediastinal organs in 10 patients (37%), pericardial effusion in 6 patients 
(22.2%) (Fig. 5.), extension of chest wall in 7 patients (25.9%), extension of diaphragm in 5 
patients (18.5%), thickening of interlober fissur in 11 patients (47.7%)(Fig. 2.), reduction in 
thoracic volume in 8 patients (29.6%)(Fig. 1.), brain metastases in only one patient (3.7%), 
pulmonary metastases in 2 patients (%7.4),(Fig. 3) hepatic metastases in 2 patients (7.4%), 
(Fig. 9) (Table1). 
 
 
  
Fig. 1. Axial contrast enhanced CT parenchymal (a.) and mediastinal sections (b.) shows 
nodular, irregular and circumferantial right sided pleural thickening in 55 year-old man. 
Note that contracted right hemithorax and anterior mediastinal lymph node (arrow head). 
We can see pleural calcification on left sided pleural surface (arrow head). 
 
 
  
Fig. 2. Axial contrast enhanced CT mediastinal (a.) and parenchymal sections (b.) shows 
right sided irregular pleural thickening and right major fissur involvement (arrow head). 
a b
a b
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Fig. 3. Axial non- contrast enhanced CT a milimetric parenchymal nodul in right middle 
lobe (arrow head). 
 
Fig. 4. Axial contrast enhanced CT show 1 cm paracardiac lymphadenopathy in 65 year old 
man with MPM. 
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Fig. 5. Axial contrast enhanced CT shows pericardial invasion and pericardial effusion. 
 
 
 
 
 
Fig. 6. Coronal (a) and axial (b) postcontrast T1 weighted images show a solitary mass with 
central necrosis into left retrocrural space at a patient with malignant pleural mesothelioma. 
a. b. 
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Radiologic Findings Rates 
Pleural Effusion 85.12% 
Pleural Thickening 100% 
Pleural Calcification 40.7% 
Thickening of Interlober Fissur 47.7% 
Reduction in Thoracic Volume 29.6% 
Mediastinal Lymphadenopathy 40.7% 
Direct Extension To Mediastinal Organs 37% 
Pericardial Effusion 22.2% 
Extension Of Chest Wall 25.9% 
Extension Of Diaphragm 18.5% 
Metastases 11.1% 
  
Table 1. Pleural mesothelioma radiologic findings 
In peritoneal mesothelioma group, the average age 60.75±10.41 (min: 42-max: 73). There 
were 2 female (25%) and 6 male (75%) patient. We found peritoneal irregularity and nodular 
thickening in 4 patients (50%)( Fig. 7a.), diffuse peritoneal thickening (omental cake) in 4 
patients (50%)(Fig. 7c., 8a., b., c.), ascites in 5 patients (62.5%) (Fig. 7., 8. ), extension of adject 
tissue in only one patient (2.5%) (Table 2). 
 
Radiologic Findings Rates 
Peritoneal irregularity and nodular thickening 50% 
Diffuse peritoneal thickening 50% 
Ascites 62.5% 
Extension of adject tissue 2.5% 
Table 2. Malignant peritoneal mesothelioma radiologic findings 
 
 
  
a b
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Fig. 7. Malignant peritoneal mesothelioma. a. Contrast enhanced CT scan shows nodular 
peritoneal thickening. b. Axial contrast enhanced CT shows perisplenic and perihepatic 
large amount of ascites. c. Axial contrast enhanced CT shows diffuse peritoneal thickening 
with omental cake. 
 
Fig. 8. Diffuse irregular thickening of parietal peritoneum with omental cake is hypointense 
on axial T2 Weighted images (a), hyperintense on FIESTA sequence (b), shows minimal 
enhancement on post-gadolinium axial T1 Weighted images (c). We can see perihepatic 
minimal ascites. 
a b
c
b
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Fig. 9. Coronal post gadolinium T1 weighted image shows perihepatic focal parietal 
peritoneal thickening and hepatic metastases. 
4. Discussion 
The association of history, examination, radiology and pathology is essential in the 
diagnosis of mesothelioma. Radiological imaging is important for the diagnosis, staging and 
management of mesothelioma.  
4.1 Pleural mesothelioma 
Intravenous contrast-enhanced CT is the primary imaging modality for suspected 
malignant mesothelioma. CT can show the whole pleural surface and diaphragm. CT 
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findings that is seen mostly are nodular pleural thickening, unilateral pleural effusion, 
pleural calcification, thickening of interlobar fissur, reduction of thoracic volume (Wang 
et al., 2004, Ismail-Khan et al., 2006). Pleural calcification is seen approximately 20% of 
cases (Moore et al., 2008, Wang et al., 2004). Typically, both the visceral and parietal 
pleurae are involved. Malignant pleural thickening characteristically is circumferantial, 
nodular and > 1 cm. Also, mediastinal pleural involvement is often detected (Ismail-Khan 
et al., 2006). Malignant pleural mesothelioma is locally aggressive with invasion of the 
chest wall, mediastinum and diaphragm. Obliteration of extrapleural fat planes, invasion 
of intercostal muscles, displacement of ribs, and bone destruction are findings of chest 
wall involvement. Heart, esophagus, trachea and major vascular structures of 
mediastinum may be involved by tumor. Nodular pericardial thickening and pericardial 
effusion refers to pericardial invasion by malignant pleural mesothelioma. Obliteration of 
surrounding fat planes of mediastinal organs, covering of vascular structure more than 
50% is a strong evidence of invasion (Moore et al., 2008, Wang et al., 2004, Miller et al., 
1996, Patz et al., 1992).  
Pulmonary metastases of MPM presenting as nodules and masses and, rarely, diffuse 
miliary nodules may be seen at CT. Chest CT may also rarely demonstrate extrathoracic 
spread of MPM. Metastasis to the hilar and mediastinal lymph nodes is present at autopsy 
in approximately 40-45% of patients with MPM ( Miller et al., 1996, Patz et al., 1992, Dynes 
et al., 1992). 
MRI screening is not used routinely in the assessment of malignant mesothelioma, however 
in patients with potentially resectable disease, MRI can help to provide additional staging 
information over and above CT. Using gadolinium enhancement, MRI can advance the 
identification of tumor extension into the diaphragm or chest wall. MRI also is preferred in 
some patients whom intravenous iodinated contrast is contraindicated.  
Malignant pleural mesothelioma is typically isointense or slightly hyperintense on T1-
weighted images and moderately hyperintense on T2-weighted images relative to adjacent 
chest wall muscle. After the gadolinium injection, MPM shows enhancement. MR imaging is 
superior to CT for showing invasion of the diaphragm and invasion of endothoracic fascia 
or a single chest wall focus (Moore et al., 2008, Miller et al., 1996, Patz et al., 1992).  
The radiologic differential diagnosis includes metastatic pleural disease, pleural lymphoma, 
asbestos releated benign pleural disease, and tuberculous empyema. Pleural rind, nodular 
pleural thickening, pleural thickening greater than 1 cm, and mediastinal pleural 
involvement favor malignant pleural disease. Pleural calsification is usually seen in benign 
process. Mesothelioma can not be distinguished from metastatic pleural disease on CT. 
Discrimination between epithelial types of mesothelioma and metastatic adenocarcinoma 
requires histochemical, immunohistochemical, and ultrastructural analysis. The presence of 
hilar-mediastinal adenopathy may be helpful in differentiating metastases and lymphoma 
from mesothelioma. The radiologic criteria for unresectability are tumor encasing 
diaphragm, invasion of extrapleural soft tissue, infiltration, displacement, or seperation of 
ribs by tumor, or bone destruction (Moore et al., 2008, Dynes et al., 1992, Barreiro et al., 2006, 
Jeong et al., 2008).  
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Morphologically malignant pleural mesothelioma can be seen in three forms: epithelial, 
sarcomatous, and mixed. The mixed form is usually mentioned as biphasic or bimorphic. 
Mixed tumors are composed of both epithelial and sarcomatous components. Epithelial 
mesotheliomas have a better diagnosis than sarcomatous and mixed tumors so differential 
diagnosis is very important for determining the prognosis. Epithelial malignant 
mesotheliomas consist of cells that are similar to normal mesothelial cells. The cells form a 
tubulopapillary or trabecular pattern. Epithelial malignant mesothelioma may also show 
prominent secretory changes, microglandular patterns, signet cell structure, or desmoplastic 
responses that make these tumors difficult to differentiate from adenocarcinomas based on 
routine histologic analysis alone. The sarcomatous pattern of malignant mesothelioma is 
typically consist of closely packed spindle cells. No immunohistochemical markers are 
spesific for malignant mesotheliomas and so there are some immunohistochemical markers 
such as calretinin thrombomodulin, and cytokeratin 5/6 to differentiate from metastatic 
adenocarcinomas and soft tissue sarcomas that have similar to histologic appearances (Levy 
et al., 2008). (Fig. 10). 
4.2 Peritoneal mesothelioma 
Approximately 35% of all mesotheliomas arise only from the peritoneum. There are three 
pathologic subtypes of peritoneal mesothelioma: Malignant mesothelioma, cystic 
mesothelioma, or well-differentiated papillary mesothelioma. CT findings of these subtypes 
are different from each other (Park et al., 2008). 
Malignant peritoneal mesothelioma is seen at fifth and sixth decades. Asbestos exposure 
is a predisposing factor. We can see two different apperance at CT. Dry apparence is 
characterized with peritoneal based masses and wet apparence is characterized ascites, 
irregular or nodular peritoneal thickening and omental mass may be seen at CT. 
Peritoneal carcinomatosis, serous papillary carcinoma of peritoneum, tuberculous 
peritonitis and peritoneal lymphomatosis should be thought in differential diagnosis. It is 
very difficult to do differential diagnosis by using only CT. Prominent ascites and less 
severe peritoneal thickening is seen in peritoneal carcinomatosis. The incidence of liver 
metastasis and lymphadenopathy is also higher in peritoneal carcinomatosis. Serous 
papillary carcinoma is found predominantly in elderly women and postmenopausal 
women. We must think tuberculous peritonitis if we see smooth peritoneal thickening, 
mesenteric lymphadenopathy with central necrosis, ascites with high attenuation, and 
splenomegaly at CT. Diffuse retroperitoneal and mesenteric lympadenopathy and the lack 
of omental involvement may misgive about lymphomatosis (Park et al., 2008, Levy et al., 
2008). 
Cystic mesothelioma is a benign tumor that is occur mainly in young to middle-aged 
women. It is usually associated with a history of previous abdominal surgery or pelvic 
inflammatory disease. Relationship between asbestos exposure and cystic mesothelioma has 
not been reported. Involvement of pelvic region is typical. Hormonal therapy is usually 
useful for treatment of cystic mesothelioma. Multilocular cystic mass, multiple unilocular 
cystic thin-walled cysts, or a unilocular cystic mass. Cystic lymphangioma, cystic epithelial 
neoplasms of the ovaries and endometriosis is thought in the differantial diagnosis. Cystic 
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Fig. 10. a. Malignant mesothelioma that shows papillary formation and desmoplastic 
stromal reaction, b. Biphasic malignant mesothelioma which consists of epitheloid and 
spindle cells, c. Malignant mesothelioma cells that show immunreactive with calretinen, d. 
Pleomorphic mesothelial cells (May Gruwald Giemsa) 
b. 
c. d. 
a. 
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lymphangioma is seen in younger patients than cystic mesothelioma. It does not show 
regional predilection. Thick-walled cysts, thick internal septa, and high-attenuation internal 
debris favor the diagnosis of endometriosis. Well-differentiated papillary mesotheliomas is 
found reproductive-age women. Peritoneal thickening, multiple peritoneal nodules, omental 
infiltration and ascites may be seen at CT. It should be thought as the same disease that is 
thought in malignant peritoneal mesothelioma in differential diagnosis (Park et al., 2008, 
Levy et al., 2008., Pickhardt et al., 2005). 
5. Conclusion 
Malignant mesothelioma can be difficult to diagnose. Neither CT scanning nor MRI 
provides an unequivocal diagnosis of mesothelioma; tissue biopsy is required for the 
definitive diagnosis (Wang et al., 2004, Miller et al., 1996, Patz et al., 1992, Pickhardt et al., 
2005, Zahid I et al. 2011).  
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